GS
GlobeStar Therapeutics Corporation
GSTC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $124.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive EV/EBITDA 72.89x
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
100 /100
Excellent ROIC 174.56%
ROA N/A
Asset turnover N/A
Debt
0 /100
High Int. coverage -20.28x
Net debt/EBITDA 54.43x
Current ratio 0.00x
Stability
27 /100
Unstable EPS volatility 620.41%
Profitable years 0
Beta 1.11x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GSTC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James C. Katzaroff
Employees
0
Headquarters
New York